Impact of adjuvant chemotherapy for gliomatosis cerebri

BMC Cancer

Volumn 10, Issue , 2010, Pages 424-

  Kong, Doo Sik ^a   Kim, Sung T ^a   Lee, Jung Il ^a   Suh, Yeon Lim ^a   Lim, Do H ^a   Kim, Won S ^a   Kwon, Ki Hoon ^a   Park, Kwan ^a   Kim, Jong H ^a   Nam, Do Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CHEMOTHERAPY, ADJUVANT; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DACARBAZINE; FEMALE; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, NEUROEPITHELIAL; NEOPLASMS, RADIATION-INDUCED; PROCARBAZINE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE; YOUNG ADULT;

EID: 77955495437     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-424     Document Type: Article

References (30)

1. Couch JR, Weiss SA. Gliomatosis cerebri. Report of four cases and review of the literature. Neurology 1974, 24(6):504-511.
2. del Carpio-O'Donovan R, Korah I, Salazar A, Melancon D. Gliomatosis cerebri. Radiology 1996, 198(3):831-835.
3. Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G. Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol 1985, 4(4):135-148.
4. Choi D, Schulz U, Seex K. Gliomatosis cerebri: a brain tumour which is too difficult to treat?. Scott Med J 1998, 43(3):84-86.
5. Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vorwerk C, Von Deimling A, Van Landeghem F, Meyermann R, Bornemann A, Muller A, Romeike B, StoltenburgDidinger G, Wickboldt J, Pilz P, Dietzmann K. Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol (Berl) 2003, 105(6):529-536.
6. Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH, Choi KS, Cho BK. Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir (Wien) 1998, 140(8):755-762. 10.1007/s007010050176, 9810441.
7. Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 2003, 56(4):1137-1146. 10.1016/S0360-3016(03)00293-1, 12829152.
8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007, 114(2):97-109. 10.1007/s00401-007-0243-4, 1929165, 17618441.
9. Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD. Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 1995, 10(1):37-45. 10.1177/088307389501000111, 7539465.
10. Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY. Initial chemotherapy in gliomatosis cerebri. Neurology 2004, 63(2):270-275.
11. Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. Gliomatosis cerebri: a review of 22 cases. Neurosurgery 2003, 53(2):261-271. discussion 271, 10.1227/01.NEU.0000073527.20655.E6, 12925240.
12. Sanson M, Napolitano M, Cartalat-Carel S, Taillibert S. Gliomatosis cerebri. Rev Neurol (Paris) 2005, 161(2):173-181.
13. Kaloshi G, Everhard S, Laigle-Donadey F, Marie Y, Navarro S, Mokhtari K, Idbaih A, Ducray F, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. Neurology 2008, 70(8):590-595. 10.1212/01.wnl.0000299896.65604.ae, 18285534.
14. Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quinones-Hinojosa A. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg 2010, 112(1):10-7. 10.3171/2008.10.JNS08608, 19361270.
15. Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature. Neurol Res 2009, 31(9):931-9. 10.1179/174313209X395454, 19215664.
16. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, Turnbull DH. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003, 49(5):848-855. 10.1002/mrm.10446, 12704767.
17. Law M, Hamburger M, Johnson G, Inglese M, Londono A, Golfinos J, Zagzag D, Knopp EA. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging. Technol Cancer Res Treat 2004, 3(6):557-565.
18. Nagesh V, Chenevert TL, Tsien CI, Ross BD, Lawrence TS, Junck L, Cao Y. Quantitative characterization of hemodynamic properties and vasculature dysfunction of high-grade gliomas. NMR Biomed 2007, 20(6):566-577. 10.1002/nbm.1118, 17221937.
19. Pivawer G, Law M, Zagzag D. Perfusion MR imaging and proton MR spectroscopic imaging in differentiating necrotizing cerebritis from glioblastoma multiforme. Magn Reson Imaging 2007, 25(2):238-243. 10.1016/j.mri.2006.09.028, 1847362, 17275620.
20. Yang S, Law M, Zagzag D, Wu HH, Cha S, Golfinos JG, Knopp EA, Johnson G. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol 2003, 24(8):1554-1559.
21. Shin YM, Chang KH, Han MH, Myung NH, Chi JG, Cha SH, Han MC. Gliomatosis cerebri: comparison of MR and CT features. AJR Am J Roentgenol 1993, 161(4):859-862.
22. Pyhtinen J. Proton MR spectroscopy in gliomatosis cerebri. Neuroradiology 2000, 42(8):612-615. 10.1007/s002340000343, 10997568.
23. Pyhtinen J, Paakko E. A difficult diagnosis of gliomatosis cerebri. Neuroradiology 1996, 38(5):444-448. 10.1007/BF00607270, 8837088.
24. Spagnoli MV, Grossman RI, Packer RJ, Hackney DB, Goldberg HI, Zimmerman RA, Bilaniuk LT. Magnetic resonance imaging determination of gliomatosis cerebri. Neuroradiology 1987, 29(1):15-18. 10.1007/BF00341031, 3822096.
25. Peretti-Viton P, Brunel H, Chinot O, Daniel C, Barrie M, Bouvier C, Figarella-Branger D, Fuentes S, Dufour H, Grisoli F. Histological and MR correlations in Gliomatosis cerebri. J Neurooncol 2002, 59(3):249-259. 10.1023/A:1019934901750, 12241123.
26. Keene DL, Jimenez C, Hsu E. MRI diagnosis of gliomatosis cerebri. Pediatr Neurol 1999, 20(2):148-151. 10.1016/S0887-8994(98)00132-5, 10082346.
27. Essig M, Schlemmer HP, Tronnier V, Hawighorst H, Wirtz R, van Kaick G. Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri. Eur Radiol 2001, 11(2):303-308. 10.1007/s003300000587, 11218032.
28. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005, 353(8):811-822. 10.1056/NEJMra043666, 16120861.
29. Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger P. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci USA 2006, 103(44):16466-16471. 10.1073/pnas.0607668103, 1618812, 17056721.
30. Kong DS, Kim MH, Park WY, Suh YL, Lee JI, Park K, Kim JH, Nam DH. The progression of gliomas is associated with cancer stem cell phenotype. Oncol Rep 2008, 19(3):639-643.